Literature DB >> 27132229

Lentivirus-mediated PGC-1α overexpression protects against traumatic spinal cord injury in rats.

Jianzhong Hu1, Ye Lang1, Tao Zhang2, Shuangfei Ni1, Hongbin Lu3.   

Abstract

Peroxisome proliferator-activated receptor-γ coactivator-1 alpha (PGC-1α) is a crucial neuronal regulator in the brain. However, its role in the spinal cord and the underlying regulating mechanisms remain poorly understood. Our previous study demonstrated that PGC-1α is significantly down-regulated following acute spinal cord injury (SCI) in rats. The current study aimed to explore the effects of PGC-1α overexpression on the injured spinal cord by establishing a contusive SCI model in adult Sprague-Dawley rats, followed by immediate intraspinal injection of lentiviral vectors at rostral and caudal sites 3mm from the lesion epicenter. Hindlimb motor function was monitored using the Basso-Beattie-Bresnahan Locomotor Rating Scale (BBB scores), and cords were collected. Transfection efficiency analysis showed that lentivirus successfully induced enhanced PGC-1α expression. This resulted in attenuated apoptotic changes and a greater number of surviving spinal neurons, as determined by transmission electron microscopy and Nissl staining, respectively. Western blot and immunofluorescence analyses revealed increased growth-associated protein 43 and 5-hydroxytryptamine expression, two key markers of axonal regeneration. Importantly, BBB scores showed improved hindlimb motor functional recovery. Moreover, quantitative real-time polymerase chain reaction analysis demonstrated significantly inhibited RhoA, ROCK1, and ROCK2 mRNA expression, revealing a potential mechanism of PGC-1α overexpression following traumatic SCI. Altogether, these results suggest that gene delivery of PGC-1α exerts a significant neuroprotective effect following traumatic SCI, which could serve as a promising treatment for repair of the injured cord, and RhoA-ROCK pathway inhibition may partially underlie this neuroprotection.
Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PGC-1α; RhoA–ROCK pathway; axonal regeneration; lentivirus; neuronal apoptosis; spinal cord injury

Mesh:

Substances:

Year:  2016        PMID: 27132229     DOI: 10.1016/j.neuroscience.2016.04.031

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Kristan H Cleveland; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2019-11-27       Impact factor: 4.030

2.  Short hairpin RNA interference targeting interleukin 1 receptor type I in the paraventricular nucleus attenuates hypertension in rats.

Authors:  Peng Lu; Shu-Jun Jiang; Hong Pan; Ai-Li Xu; Gui-Hua Wang; Chun-Lei Ma; Zhen Shi
Journal:  Pflugers Arch       Date:  2017-11-16       Impact factor: 3.657

Review 3.  Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target.

Authors:  Natalie E Scholpa; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2017-09-21       Impact factor: 4.030

4.  PGC-1α protects against oxidized low-density lipoprotein and luteinizing hormone-induced granulosa cells injury through ROS-p38 pathway.

Authors:  Ying Liu; Jianjun Zhai; Jing Chen; Xiaomin Wang; Tingru Wen
Journal:  Hum Cell       Date:  2019-04-16       Impact factor: 4.174

5.  Overexpressed ski efficiently promotes neurorestoration, increases neuronal regeneration, and reduces astrogliosis after traumatic brain injury.

Authors:  Yu Zhai; Shi-Yang Ye; Qiu-Shi Wang; Ren-Ping Xiong; Sheng-Yu Fu; Hao Du; Ya-Wei Xu; Yan Peng; Zhi-Zhong Huang; Nan Yang; Yan Zhao; Ya-Lei Ning; Ping Li; Yuan-Guo Zhou
Journal:  Gene Ther       Date:  2022-02-08       Impact factor: 5.250

Review 6.  Mitochondrial function in spinal cord injury and regeneration.

Authors:  Paula G Slater; Miguel E Domínguez-Romero; Maximiliano Villarreal; Verónica Eisner; Juan Larraín
Journal:  Cell Mol Life Sci       Date:  2022-04-13       Impact factor: 9.261

Review 7.  [Advances of the role of mitochondrial dysfunction in the spinal cord injury and its relevant treatments].

Authors:  Xin Miao; Junqing Lin; Xianyou Zheng
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-07-15

Review 8.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

9.  Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β2-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury.

Authors:  Natalie E Scholpa; Hannah Williams; Wenxue Wang; Daniel Corum; Aarti Narang; Stephen Tomlinson; Patrick G Sullivan; Alexander G Rabchevsky; Rick G Schnellmann
Journal:  J Neurotrauma       Date:  2018-11-16       Impact factor: 5.269

Review 10.  Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity.

Authors:  Gopi Suresh Oggu; Shyama Sasikumar; Nirosha Reddy; Kranthi Kiran Reddy Ella; Ch Mohan Rao; Kiran Kumar Bokara
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 6.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.